Skip to content

Effect of Fenugreek Seed Extract on inflammation in Patients with Type 2 Diabetes

The Effect of Fenugreek Seed Extract Supplementation on Body Composition, Blood Pressure, IL-1ß, Adiponectin, and Depression in Patients with Type 2 Diabetes: Randomized Double-Blind Controlled Clinical Trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20210407050880N1
Enrollment
46
Registered
2021-12-25
Start date
2021-08-06
Completion date
Unknown
Last updated
2022-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes. Type 2 diabetes mellitus

Interventions

Intervention 1: Intervention group: Dry extract of fenugreek seeds of Barij Essence Company entitled "Glucorx B" (containing 46.4 micrograms of luteolin per tablet), in the form of three 335 mg tablet
Therefore, reducing calories per person will not be a fixed amount. BMR (using the Mifflin formula) will be multiplied by physical activity and TEF to calculate calories. People in this group will be

Sponsors

Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patients in the age range of 30-65 years Having at least 6 months of diabetes history (according to criteria of American Diabetes Association) BMI between 25 and 35 Taking blood sugar lowering drugs No herbs at least 3 months before the study to be used routinely Willingness to participate in the project

Exclusion criteria

Exclusion criteria: Pregnancy or breastfeeding or its intention Kidney, liver, gastrointestinal, thyroid, and rheumatic diseases Allergy to plants of the Fabaceae family

Design outcomes

Primary

MeasureTime frame
Inflammatory marker IL-1ß. Timepoint: Before intervention and 2 months after intervention. Method of measurement: Measurement of serum level by ELISA kit.;Adiponectin. Timepoint: Before intervention and 2 months after intervention. Method of measurement: Measurement of serum level by ELISA kit.;??Body Composition. Timepoint: Before intervention and 2 months after intervention. Method of measurement: By Tanita Body Analyzer.;Blood pressure. Timepoint: Before intervention and 2 months after intervention. Method of measurement: Mercury barometer.;Depression. Timepoint: Before intervention and 2 months after intervention. Method of measurement: PHQ-9 questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactLaleh Fakhr

Tabriz University of Medical Sciences

lalehfakhrnut@gmail.com+98 41 3335 5921

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026